BBNX (BBNX) reported R&D of $10.36M in Q1 2026.

How has BBNX's R&D changed year-over-year?

BBNX's R&D increased by 36.4% year-over-year, from $7.59M to $10.36M.

What is the long-term trend for BBNX's R&D?

Over 2 years (2023 to 2025), BBNX's R&D has grown at a 39.2% compound annual growth rate (CAGR), from $17.94M to $34.79M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

BBNX BBNX R&D

R&D at other companies

InsuletPODD

$89.7M+50.5%

Tandem Diabetes CareTNDM

$46.04M-8.3%

MedtronicMDT

$671M-1.9%

Halozyme TherapeuticsHALO

$25.56M+72.7%

Other financials

Income statement

See full

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

See full

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

See full

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

See full

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

See full

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

See full

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BBNX's R&D?: BBNX (BBNX) reported R&D of $10.36M in Q1 2026.
How has BBNX's R&D changed year-over-year?: BBNX's R&D increased by 36.4% year-over-year, from $7.59M to $10.36M.
What is the long-term trend for BBNX's R&D?: Over 2 years (2023 to 2025), BBNX's R&D has grown at a 39.2% compound annual growth rate (CAGR), from $17.94M to $34.79M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.